LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 51 filers reported holding LEGEND BIOTECH CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,625,744 | +70.4% | 262,405 | +22.4% | 0.01% | +60.0% |
| Q2 2023 | $10,341,164 | 0.0% | 214,458 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $10,341,164 | +13.5% | 214,458 | +17.5% | 0.01% | 0.0% |
| Q4 2022 | $9,110,251 | -100.0% | 182,497 | -63.1% | 0.01% | -54.5% |
| Q3 2022 | $20,190,941,000 | -24.3% | 494,876 | +2.0% | 0.01% | -21.4% |
| Q2 2022 | $26,682,645,000 | +344.6% | 485,139 | +193.8% | 0.01% | +366.7% |
| Q1 2022 | $6,000,897,000 | +7.0% | 165,132 | +37.2% | 0.00% | +50.0% |
| Q4 2021 | $5,608,768,000 | +427.1% | 120,334 | +381.3% | 0.00% | +100.0% |
| Q2 2020 | $1,064,000,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $89,605,000 | 22.89% |
| Paradigm Biocapital Advisors LP | 978,596 | $53,823,000 | 10.73% |
| FengHe Fund Management Pte. Ltd. | 475,263 | $26,139,000 | 10.25% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,222,342 | $67,229,000 | 9.65% |
| HHLR ADVISORS, LTD. | 4,436,617 | $244,014,000 | 5.23% |
| Iron Triangle Partners LP | 495,329 | $27,243,000 | 3.53% |
| Parkman Healthcare Partners LLC | 117,807 | $6,479,000 | 2.39% |
| AtonRa Partners | 28,172 | $1,549,000 | 1.42% |
| Vivo Capital, LLC | 244,375 | $13,441,000 | 1.35% |
| Avidity Partners Management LP | 1,000,000 | $55,000,000 | 1.26% |